Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

Fig. 2

Treatment with the c-Met inhibitor PF induced DR5 upregulation. DR5 expression levels in MFH-ino (a), SW872 (b), and HT1080 (c) cells after 48 h of incubation with PF as measured via flow cytometry. The left panel shows control cells with DMSO (shaded gray histogram) and the right panel shows cells treated with 10 μM PF (bold black open histogram)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us